









Markets
/
Stocks
/
nasdaq-usna
/

USANA Health Sciences Inc

USNA

21.340USD

+0.530+2.55%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

389.92MMarket Cap

23.53P/E TTM



USANA Health Sciences Inc

21.340

+0.530+2.55%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of USANA Health Sciences Inc

Currency: USD Updated: 2026-02-05

Key Insights

USANA Health Sciences Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 57 out of 96 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 39.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

USANA Health Sciences Inc's Score

Industry at a Glance

Industry Ranking

57 / 96

Overall Ranking

362 / 4521

Industry

Food & Tobacco

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

USANA Health Sciences Inc Highlights

StrengthsRisks

USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

Overvalued

The company’s latest PE is 22.95, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 11.05M shares, decreasing 9.73% quarter-over-quarter.

Held by HACAX

Star Investor HACAX holds 7.51K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.10.

Analyst Rating

Based on 0 analysts

Current Rating

39.000

Target Price

+80.06%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-05

The current financial score of USANA Health Sciences Inc is 6.80, ranking 60 out of 96 in the Food & Tobacco industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 213.67M, representing a year-over-year increase of 6.72%, while its net profit experienced a year-over-year increase of 161.49%.

Score

Industry at a Glance

Previous score

6.80

Change



Financials

9.82

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

5.29

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.57

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.28

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.05

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

USANA Health Sciences Inc's Company Valuation

Currency: USD Updated: 2026-02-05

The current valuation score of USANA Health Sciences Inc is 8.78, ranking 10 out of 96 in the Food & Tobacco industry. Its current P/E ratio is 22.95, which is 32.49% below the recent high of 30.40 and 48.81% above the recent low of 11.75.

Score

Industry at a Glance

Previous score

8.78

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 57/96

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-05

No earnings forecast score is currently available for USANA Health Sciences Inc. The Food & Tobacco industry's average is 7.41. The average price target is 39.00, with a high of 39.00 and a low of 39.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-05

The current price momentum score of USANA Health Sciences Inc is 6.69, ranking 66 out of 96 in the Food & Tobacco industry. Currently, the stock price is trading between the resistance level at 22.74 and the support level at 19.05, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.75

Change

-0.06

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.282

Neutral

RSI(14)

52.923

Neutral

STOCH(KDJ)(9,3,3)

40.306

Buy

ATR(14)

0.794

Low Volatility

CCI(14)

-67.511

Neutral

Williams %R

58.647

Sell

TRIX(12,20)

0.255

Sell

StochRSI(14)

70.170

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

21.030

Buy

MA10

21.426

Sell

MA20

21.414

Sell

MA50

20.513

Buy

MA100

21.745

Sell

MA200

26.053

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-05

The current institutional shareholding score of USANA Health Sciences Inc is 5.00, ranking 44 out of 96 in the Food & Tobacco industry. The latest institutional shareholding proportion is 60.43%, representing a quarter-over-quarter decrease of 1.99%. The largest institutional shareholder is Richard Pzena, holding a total of 1.21M shares, representing 6.63% of shares outstanding, with 12.79% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Gull Global, Ltd.

7.74M

-1.81%

BlackRock Institutional Trust Company, N.A.

1.54M

+0.13%

Pzena Investment Management, LLC

Star Investors

1.21M

+1.20%

Renaissance Technologies LLC

Star Investors

1.13M

-2.54%

The Vanguard Group, Inc.

Star Investors

1.03M

+4.37%

Dimensional Fund Advisors, L.P.

915.05K

+1.93%

State Street Investment Management (US)

427.49K

+0.27%

Charles Schwab Investment Management, Inc.

288.08K

+26.27%

Jacobs Levy Equity Management, Inc.

264.97K

-24.42%

American Century Investment Management, Inc.

260.56K

+2.17%

Risk Assessment

Currency: USD Updated: 2026-02-05

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Tobacco domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of USANA Health Sciences Inc is 4.37, ranking 57 out of 96 in the Food & Tobacco industry. The company's beta value is 0.64. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. USANA Health Sciences Inc’s latest ESG disclosure leads the Food & Tobacco industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.